[

ema

]
Ahead of the meeting on the Moderna vaccine, the agency said in a tweet that its experts were “working hard to clarify all outstanding issues with the company.”(Reuters File Photo)

European medicines agency ponders approval for Moderna’s Covid-19 vaccine

Amsterdam | By Associated Press | Posted by Srivatsan K C
PUBLISHED ON JAN 06, 2021 01:25 PM IST
The meeting of the European Medicines Agency’s human medicines committee (CHMP) comes amid high rates of infections in many EU countries and strong criticism of the slow pace of vaccinations across the region of some 450 million people.
If EMA scientists conclude that the Pfzier/BioNTech Covid-19 vaccine is safe, officials are expected to give conditional approval for it to be used across the 27-nation bloc.(Reuters File Photo)
If EMA scientists conclude that the Pfzier/BioNTech Covid-19 vaccine is safe, officials are expected to give conditional approval for it to be used across the 27-nation bloc.(Reuters File Photo)

EU regulator meets to discuss approval of Covid-19 vaccine

Amsterdam | By Associated Press | Posted by Srivatsan K C
PUBLISHED ON DEC 21, 2020 02:42 PM IST
The closed-doors meeting comes weeks after the shot was granted permission under emergency provisions by regulators in Britain and the United States.
A second Covid-19 vaccine moved closer to joining the US fight against the pandemic on Dec. 17, 2020.(AP File Photo)
A second Covid-19 vaccine moved closer to joining the US fight against the pandemic on Dec. 17, 2020.(AP File Photo)

EMA brings Moderna Covid-19 vaccine decision forward to Jan 6

The Hague | By Agence France-Presse | Posted by Kanishka Sarkar
UPDATED ON DEC 17, 2020 11:27 PM IST
The Amsterdam-based European Medicines Agency said US-based Moderna had sent extra data ahead of schedule, so the regulator had “scheduled an extraordinary meeting on 6 January 2021 to conclude its assessment, if possible”.
Given that the Covid-19 vaccine developed by Pfizer and BioNTech was pioneered in Germany, it became difficult for the European leaders to explain to their citizens how the US and the UK approved the vaccine before the EU.(Reuters | Representational image)
Given that the Covid-19 vaccine developed by Pfizer and BioNTech was pioneered in Germany, it became difficult for the European leaders to explain to their citizens how the US and the UK approved the vaccine before the EU.(Reuters | Representational image)

EU’s Covid-19 vaccinations to begin from December 27, confirms European Commission president

Hindustan Times, New Delhi | By hindustantimes.com | Edited by Srivatsan K C
UPDATED ON DEC 17, 2020 10:12 PM IST
European Medicines Agency (EMA) has said in a press release that its human medicines body, the Committee for Medicinal Products for Human Use (CHMP), is evaluating data available from Pfizer and BioNTech to provide Conditional Marketing Authorization (CMA).
SHARE
Story Saved